| Malignant Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived200 of 454show all (up to 200) |
|---|
| → investigated in trials for | Cyclophosphamidesmall molecule 770 trials (195 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 770 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 605 trials (151 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 605 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cytarabinesmall molecule 600 trials (119 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 600 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Azacitidinesmall molecule 352 trials (144 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 352 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Venetoclaxsmall molecule 316 trials (194 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 316 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 312 trials (51 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 312 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 311 trials (104 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 311 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 292 trials (93 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 292 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal_antibody 283 trials (127 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 283 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rituximabmonoclonal antibody 278 trials (69 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 278 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal_antibody 258 trials (98 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 258 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall_molecule 255 trials (45 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 255 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 242 trials (19 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 242 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Busulfansmall molecule 240 trials (39 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 240 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 237 trials (66 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 237 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall_molecule 234 trials (79 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 234 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenibsmall molecule 221 trials (23 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 221 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 220 trials (68 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 220 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall molecule 217 trials (56 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 217 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 210 trials (57 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 210 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 209 trials (55 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 209 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall_molecule 197 trials (45 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 197 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 193 trials (63 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 193 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalansmall molecule 189 trials (37 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 189 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 181 trials (30 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 181 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daunorubicinsmall molecule 169 trials (39 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 169 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Decitabinesmall molecule 162 trials (42 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 162 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall molecule 151 trials (64 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 151 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 149 trials (38 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 149 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Idarubicinsmall molecule 148 trials (26 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 148 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 144 trials (38 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 144 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall molecule 123 trials (31 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 123 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 111 trials (38 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 111 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal_antibody 109 trials (66 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 109 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 108 trials (18 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 108 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 107 trials (23 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 107 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 104 trials (17 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 104 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 103 trials (36 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 103 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitoxantronesmall molecule 103 trials (11 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 103 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 96 trials (48 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 96 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall molecule 96 trials (25 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 96 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Clofarabinesmall molecule 95 trials (5 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 95 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 89 trials (37 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 89 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 86 trials (9 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 86 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temozolomidesmall molecule 86 trials (29 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 86 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thiotepasmall molecule 84 trials (24 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 84 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 83 trials (43 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 83 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mercaptopurinesmall molecule 81 trials (19 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 81 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemtuzumab Ozogamicinadc 78 trials (14 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 78 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 76 trials (15 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 76 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 74 trials (38 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 74 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Toripalimabmonoclonal antibody 72 trials (36 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 72 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 71 trials (8 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 71 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ibrutinibsmall molecule 66 trials (20 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 66 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 66 trials (13 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 66 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 64 trials (22 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 64 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinibsmall molecule 64 trials (3 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 64 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall molecule 63 trials (10 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 63 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 62 trials (36 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 62 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alemtuzumabmonoclonal antibody 57 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 57 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trametinibsmall molecule 57 trials (10 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 57 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ifosfamidesmall molecule 56 trials (13 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 56 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinib Mesylatesmall molecule 55 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 55 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 54 trials (17 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 54 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Asparaginaseother 53 trials (3 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 53 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Blinatumomabmonoclonal antibody 52 trials (37 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 52 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 51 trials (6 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 51 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Regorafenibsmall molecule 50 trials (15 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 50 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gilteritinibsmall molecule 48 trials (24 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 48 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bendamustinesmall molecule 47 trials (12 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 47 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegaspargaseother 47 trials (12 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 47 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thioguaninesmall molecule 47 trials (9 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 47 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Arsenic Trioxidesmall molecule 46 trials (6 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 46 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cladribinesmall molecule 45 trials (14 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 45 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal antibody 43 trials (29 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 43 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tretinoinsmall molecule 41 trials (4 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 41 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 40 trials (8 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 40 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ruxolitinibsmall molecule 36 trials (16 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 36 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 36 trials (9 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 36 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinib Hydrochloridesmall molecule 34 trials (3 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 34 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Obinutuzumabmonoclonal antibody 33 trials (17 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 33 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenib Tosylatesmall molecule 33 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 33 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 33 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 33 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 31 trials (8 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 31 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFOX Regimen 30 trials (10 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Quizartinibsmall molecule 30 trials (9 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thalidomidesmall molecule 29 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 29 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Midostaurinsmall molecule 28 trials (4 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 28 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 28 trials (10 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 28 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panitumumabmonoclonal antibody 28 trials (4 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 28 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pazopanibsmall molecule 28 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 28 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selinexorsmall molecule 28 trials (11 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 28 | Observed | clinicaltrials | graph → |
| → investigated in trials for | CAPOX Regimen 27 trials (15 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 27 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dabrafenibsmall molecule 27 trials (7 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 27 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ivosidenibsmall molecule 27 trials (22 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 27 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carmustinesmall molecule 26 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Metforminsmall molecule 26 trials (3 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panobinostatsmall molecule 26 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisolonesmall molecule 26 trials (7 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zanubrutinibsmall molecule 26 trials (19 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Plerixaforsmall molecule 25 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 24 trials (6 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 24 trials (16 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enasidenibsmall molecule 24 trials (13 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ofatumumabmonoclonal antibody 24 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abemaciclibsmall molecule 23 trials (8 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ramucirumabmonoclonal antibody 23 trials (7 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall_molecule 22 trials (9 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zoledronic Acidsmall molecule 22 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Celecoxibsmall molecule 21 trials (5 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gefitinibsmall molecule 21 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinibsmall molecule 21 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lapatinibsmall molecule 21 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nilotinibsmall molecule 20 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pentostatinsmall molecule 20 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Revumenibsmall molecule 20 trials (17 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 20 trials (4 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epcoritamabmonoclonal antibody 19 trials (16 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Inotuzumab Ozogamicinadc 19 trials (14 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ponatinibsmall molecule 19 trials (7 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tipifarnibsmall molecule 19 trials (3 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alisertibsmall molecule 18 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFIRI Regimen 18 trials (3 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hydroxyureasmall molecule 18 trials (3 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitomycinsmall molecule 18 trials (5 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tagraxofuspother 18 trials (11 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mosunetuzumabmonoclonal antibody 17 trials (14 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nimotuzumabmonoclonal antibody 17 trials (4 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vemurafenibsmall molecule 17 trials (8 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aspirinsmall molecule 16 trials (3 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axitinibsmall molecule 16 trials (4 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Crizotinibsmall_molecule 16 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dinutuximabmonoclonal antibody 16 trials (10 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Omacetaxine Mepesuccinatesmall molecule 16 trials (7 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Treosulfansmall molecule 16 trials (3 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Valproic Acidsmall molecule 16 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Acalabrutinibsmall molecule 15 trials (10 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afliberceptother 15 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvocidibsmall molecule 15 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daratumumabmonoclonal antibody 15 trials (7 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nelarabinesmall molecule 15 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Niraparibsmall molecule 15 trials (6 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Osimertinibsmall molecule 15 trials (5 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Polatuzumab Vedotinadc 15 trials (11 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talazoparibsmall molecule 15 trials (7 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinorelbinesmall molecule 15 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Binimetinibsmall molecule 14 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carfilzomibother 14 trials (4 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dostarlimabmonoclonal antibody 14 trials (11 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tisagenlecleucelcell therapy 14 trials (4 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vismodegibsmall_molecule 14 trials (7 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 13 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Serplulimabmonoclonal antibody 13 trials (8 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adebrelimabmonoclonal antibody 12 trials (8 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cediranibsmall molecule 12 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzalutamidesmall molecule 12 trials (5 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Glofitamabmonoclonal antibody 12 trials (8 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pirtobrutinibsmall molecule 12 trials (8 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tanespimycinsmall molecule 12 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tazemetostatsmall molecule 12 trials (7 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vindesinesmall molecule 12 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adjuvant Chemotherapy 11 trials (6 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afatinibsmall molecule 11 trials (3 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cobimetinibsmall molecule 11 trials (6 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hydroxychloroquinesmall molecule 11 trials (3 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Idelalisibsmall molecule 11 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegargiminaseother 11 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pomalidomidesmall molecule 11 trials (5 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ribociclibsmall molecule 11 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selumetinibsmall molecule 11 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Volasertibsmall molecule 11 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ziftomenibsmall molecule 11 trials (10 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belinostatsmall_molecule 10 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cixutumumabmonoclonal antibody 10 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dacarbazinesmall molecule 10 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epirubicinsmall molecule 10 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fulvestrantsmall molecule 10 trials (3 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Guadecitabinesmall molecule 10 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Icotinibsmall molecule 10 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lorlatinibsmall molecule 10 trials (3 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pacritinibsmall molecule 10 trials (4 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 10 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bosutinibsmall molecule 9 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Brentuximab Vedotinadc 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabazitaxelsmall molecule 9 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Calaspargase Pegolother 9 trials (9 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Denosumabmonoclonal antibody 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fruquintinibsmall molecule 9 trials (4 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Glasdegibsmall molecule 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immunotherapy 9 trials (6 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ixazomibsmall molecule 9 trials (3 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nedaplatinsmall molecule 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Perifosinesmall molecule 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sonidegibsmall molecule 9 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vandetanibsmall molecule 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adagrasibsmall molecule 8 trials (4 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adavosertibsmall molecule 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alectinibsmall molecule 8 trials (6 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axicabtagene Ciloleucelgene therapy 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Neoplasm | 8 | Observed | clinicaltrials | graph → |